FIELD: pharmacology.
SUBSTANCE: invention is a pharmaceutical composition comprising recombinant interferon, metronidazole, fluconazole, boric acid and a consistently forming base, characterized by further comprising hyaluronic acid or sodium hyaluronate, the components in the composition being in a certain ratio %.
EFFECT: increased therapeutic effect by expanding the drug spectrum, including complex anti-inflammatory, antifungal, antibacterial, antiviral, acaricidal and anti-allergic action, as well as due to the prolonged treatment effect of the drug.
2 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
| GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
| THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
| EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
| EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
